MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.


Every year, 65 million obstetric and gynaecological treatments require access to the uterus. The standard use of Tenaculum forceps may be painful as well as traumatic and pose a risk of cross-contamination. Aspivix are developing a new generation of Tenaculum forceps which painlessly uses vacuum suction, reducing discomfort for the patient, eradicating the risk of bleeding and lesions and as a single use instrument avoids the risk of cross contamination.
In genecology, uterus access requires traumatic forceps. Aspivix, a new forceps gen using vacuum suction, eliminates pain, bleeding & lesion

Connect with Aspivix



2018 Finalist Switzerland

Sub industry

Medical Devices


Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.